This week, the domestic market for technical-grade pesticides operated under the intertwined influence of multiple external factors and internal industry risks; consequently, the overall market trend continued its upward trajectory. On the international front, ongoing geopolitical conflicts continued to disrupt global energy supply chains, leading to frequent price fluctuations in fundamental energy sources such as crude oil. This directly drove up production-side costs—particularly for raw materials—making it a pivotal external variable influencing product pricing. On the domestic industry front, recent safety incidents involving nitration processes have put the sector on high alert; as a result, production controls for related high-sensitivity processes have become increasingly stringent. Certain technical-grade pesticide varieties that rely on nitration processes now face uncertainties regarding production capacity utilization, placing significant pressure on the supply side. Meanwhile, the recently concluded CAC Global Agrochemical Exhibition—widely regarded as a bellwether for the industry—brought together suppliers and buyers from both domestic and international markets. The global procurement demand, new product R&D updates, and trade cooperation signals emerging from the exhibition have provided key reference points for short-term market sentiment as well as medium-to-long-term market trends for technical-grade pesticides. Under the combined impact of these multiple factors, prices, transaction volumes, and inventory levels across various categories of technical-grade pesticides experienced significant volatility this week, with many manufacturers opting to withhold price quotes and decline new orders.

Herbicide Market

On February 18, 2026, President Trump signed an executive order invoking the *Defense Production Act*, designating elemental phosphorus and glyphosate-based herbicides as critical materials for national defense. This executive order could accelerate the strategic competition for global phosphorus resources; while it may impact the structure of export orders in the short term, it could potentially enhance the bargaining power of Chinese phosphorus chemical enterprises in the long run.
The market for Glufosinate-ammonium continued its upward trend, with manufacturers shipping goods cautiously. Factory quotes stood at 29,500 RMB/ton for 95% purity material and 30,000 RMB/ton for 97% purity material.
Glufosinate-P saw its price rise in response to the upward adjustment in upstream Glufosinate-ammonium prices, with quotes (calculated on a 100% purity basis) reaching 59,000 RMB/ton.
The price of Diquat’s key raw material—bromine—rose significantly due to geopolitical tensions, with factory quotes currently standing at 21,000 RMB/ton. Cyhalofop-butyl: Pricing for the propionic acid intermediate has been temporarily suspended; with factories facing cost pressures, the quoted price stands at 112,000 RMB/ton.
Metamifop: Winter stocking policies have been released, and the market price is quoted at 170,000 RMB/ton.
Mefenacet: Quoted at 48,000 RMB/ton. Due to rising costs for key raw materials such as DEA:
Pretilachlor: Temporarily quoted at 35,000 RMB/ton.
Butachlor: Raised to 19,500 RMB/ton.
Penoxsulam: Quoted at 950,000 RMB/ton.
Oxadiargyl: Domestic market demand has increased, and market stocking has commenced; manufacturers are quoting 290,000 RMB/ton.
Oxadiazon: Domestic and export sectors are stocking up on an as-needed basis; quoted at 148,000 RMB/ton.
Bentazone: Primarily export-oriented; quoted at 75,000 RMB/ton.
Clomazone: Intermediate costs have risen significantly; factories anticipate raising their quoted price to 60,000 RMB/ton.
Oxyfluorfen: Intermediate costs have risen substantially; manufacturers are exercising caution in accepting orders and have raised the price to 145,000 RMB/ton.
Bensulfuron-methyl: Market price quoted at 150,000 RMB/ton.
Topramezone: Market competition persists, and manufacturers are continuing their winter stocking policies; quoted at 490,000 RMB/ton. Intermediate producers have suspended pricing, placing cost pressure on technical-grade manufacturers.
Tembotrione: New production capacity has increased; quoted at 230,000 RMB/ton.
Mesotrione: Quoted at 83,000 RMB/ton.
Isoxaflutole: Domestic enterprises are gradually stocking up; quoted at 320,000 RMB/ton.
Nicosulfuron: Quoted at 160,000 RMB/ton.
Rimsulfuron: Quoted at 650,000 RMB/ton.
Atrazine: Market price quoted at 21,000 RMB/ton. Due to rising costs for key raw materials such as MEA:
Acetochlor: Quoted at 20,000 RMB/ton.
Propisochlor: Quoted at 23,500 RMB/ton.
Metolachlor: Quoted at 25,000 RMB/ton. The new stocking cycle for fomesafen is gradually commencing; with upstream raw material costs under pressure, the quoted price stands at 112,000 RMB/ton.
The market for quizalofop-P-ethyl is currently characterized by price negotiations, with a quoted price of 140,000 RMB/ton.
Raw material costs for clethodim are rising rapidly, and inquiries are active; the current quoted price is 80,000 RMB/ton.
The price for sethoxydim (calculated on a 100% active ingredient basis) is quoted at 155,000 RMB/ton.
Flumioxazin is quoted at 150,000 RMB/ton.
Manufacturers of pendimethalin are continuing their "winter stocking" policies, with a quoted price of 42,500 RMB/ton.
The market for trifluralin remains largely stable, with a quoted price of 30,000 RMB/ton.
Thidiazuron is quoted at 105,000 RMB/ton.
Diuron is quoted at 35,000 RMB/ton.
Ametryn 80% WP is quoted at 28,000 RMB/ton.
Fluroxypyr-meptyl is primarily export-oriented, while domestic trade is driven mainly by replenishment orders to meet immediate needs; factory quotes stand at 85,000 RMB/ton.
Clodinafop-propargyl is primarily export-oriented, with a quoted price of 168,000 RMB/ton.
The market for diflufenican remains stable, with a quoted price of 160,000 RMB/ton.
Florasulam is quoted at 360,000 RMB/ton.